LOS ANGELES - 2020 has been a year of uncertainty, and among those most affected are non-profit organizations and kids with cancer. As the largest private funder of childhood cancer research grants, the St. Baldrick's Foundation has continued to fund the most promising research so kids with cancer can live longer and healthier lives. Despite a difficult fundraising year, St. Baldrick's is proud to award 17 new infrastructure grants, including one to Nemours/Alfred I. duPont Hospital for Children, totaling more than $819,000 to allow institutions across the country to move life-saving research forward. In this time of COVID-19, not having to travel to get cutting-edge treatment is critical to giving kids with cancer their best chance at survival. These one-year grants are focused on giving the selected institutions the ability to open, coordinate, and treat more children on clinical trials closer to where they live. Clinical trials offer both children in treatment and survivors the possibility of a better future with fewer side effects. This research also help scientists to improve upon the standard treatments of today, making significant strides towards more effective and less toxic cures for children now and in the future. "Though the rise in survivorship is something to celebrate, many treatments and their lasting effects have not changed much in decades, and for some types of childhood cancer, there still is no cure.  We can see that our investment in research is yielding results, but there is so much more to do," said Kathleen Ruddy, St. Baldrick's CEO said in a statement. "These clinical trials that St. Baldrick's is supporting will help research progress further to help more children survive and have a better quality of life after treatment." Infrastructure Grants are awarded based on the needs of the institutions and their patients, anticipated results of the grant, and local participation in St. Baldrick's fundraising events and activities.